Clinical Trial Update: PHASE III RANDOMISED TRIAL to EVALUATE FOLFOX with or WITHOUT DOCETAXEL (TFOX) AS 1st LINE CHEMOTHERAPY for LOCALLY ADVANCED or METASTATIC OESOPHAGO-GASTRIC CARCINOMA [Phase 3]

View source ↗

Summary

A Phase III randomized trial evaluating FOLFOX with or without docetaxel as first-line chemotherapy for locally advanced or metastatic esophagogastric cancer ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophagogastric Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• FOLFOX regimen (folinic acid (leucovorin) + fluorouracil + oxaliplatin)

Snippet

Sponsor: Federation Francophone de Cancerologie Digestive | Conditions: OESOPHAGO-GASTRIC CARCINOMA | Phase 3 | Status: COMPLETED